Key result
Apigenin plus doxorubicin augments cytotoxicity, cutting HepG2 cell viability by ~47% versus doxorubicin alone.
Why the study?
Systemic doxorubicin provides only marginal survival improvements in hepatocellular carcinoma, prompting evaluation of natural flavonoids to enhance doxorubicin cytotoxicity against HepG2 cells.
Do natural flavonoids augment the cytotoxicity of doxorubicin against human hepatocellular carcinoma cell line HepG2?
Do natural flavonoids augment the cytotoxicity of doxorubicin against human hepatocellular carcinoma cell line HepG2?
Apigenin and hesperidin augment the cytotoxic effect of doxorubicin against HepG2 cells, suggesting a potential role in hepatocellular carcinoma therapy.
Answers are grounded in this paper and cite their sources.
May sensitize HepG2 cells to doxorubicin via non-oxidative mechanisms; leaves open clinical translation in HCC chemoembolization.
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies, with an increasing incidence. Despite the fact that systematic chemotherapy with a doxorubicin provides only marginal improvements in survival of the HCC patients, the doxorubicin is being used in transarterial therapies or combined with the target drug - sorafenib. The aim of the study was to evaluate the effect of natural flavonoids on the cytotoxicity of the doxorubicin against human hepatocellular carcinoma cell line HepG2. METHODS: The effect of apigenin and its glycosides - cosmosiin, rhoifolin; baicalein and its glycosides - baicalin as well as hesperetin and its glycosides - hesperidin on glycolytic genes expression of HepG2 cell line, morphology and cells' viability at the presence of doxorubicin have been tested. In an attempt to elucidate the mechanism of observed results, the fluorogenic probe for reactive oxygen species (ROS), the DNA oxidative damage, the lipid peroxidation and the double strand breaks were evaluated. To assess impact on the glycolysis pathway, the mRNA expression for a hexokinase 2 (HK2) and a lactate dehydrogenase A (LDHA) enzymes were measured. The results were analysed statistically with the one-way analysis of variance (ANOVA) and post hoc multiple comparisons. RESULTS: The apigenin and the hesperidin revealed the strongest effect on the toxicity of doxorubicin. Both flavonoids simultaneously changed the expression of the glycolytic pathway genes - HK2 and LDHA, which play a key role in the Warburg effect. Although separate treatment with doxorubicin, apigenin and hesperidin led to a significant oxidative DNA damage and double strand breaks, simultaneous administration of doxorubicin and apigenin or hesperidin abolished these damage with the simultaneous increase in the doxorubicin toxicity. CONCLUSION: The obtained results indicate the existence of a very effective cytotoxic mechanism in the HepG2 cells of the combined effect of doxorubicin and apigenin (or hesperidin), not related to the oxidative stress. To explain this synergy mechanism, further research is needed, The observed intensification of the cytotoxic effect of doxorubicin by this flavonoids may be a promising direction of the research on the therapy of hepatocellular carcinoma, especially in a chemoembolization.
No takes yet. Share an insight, caveat, or question.
Korga-Plewko et al. (2019) studied Hepatocellular carcinoma (HepG2 cells). Apigenin and hesperidin with doxorubicin vs. Doxorubicin alone or control was evaluated on Cell viability (p=≤0.05). Apigenin and hesperidin significantly augmented the cytotoxicity of doxorubicin against HepG2 cells, with the doxorubicin and apigenin combination reducing cell viability to 35.62% compared to 67.77% with doxorubicin alone.
Synapse has enriched 10 related papers. Consider them for comparative context: